-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on BeOne Medicines, Raises Price Target to $463

Benzinga·11/06/2026 15:33:34
Listen to the news
Citizens analyst Reni J. Benjamin maintains BeOne Medicines (NASDAQ:ONC) with a Market Outperform and raises the price target from $405 to $463.